Literature DB >> 33768303

Strategies to prevent drug incompatibility during simultaneous multi-drug infusion in intensive care units: a literature review.

Laura Négrier1, Anthony Martin Mena2, Gilles Lebuffe2, Pascal Odou2, Stéphanie Genay2, Bertrand Décaudin2.   

Abstract

PURPOSE: Drug protocols in intensive care units may require the concomitant administration of many drugs as patients' venous accesses are often limited. A major challenge for clinicians is to limit the risk of simultaneously infusing incompatible drugs. Incompatibilities can lead to the formation of particles and inactivation of drugs, whose consequences on the body have already been indicated. Our objective was to assess current strategies to counter the risk of incompatible infusions and control the resulting clinical consequences.
METHODS: This review was independently conducted by three investigators in respect of the PRISMA statement. Three online databases were consulted. Full-text articles, notes, or letters written in English or French, published or in press between the 1990s and the end of February 2020, with clinical study design, were eligible. Parameters of interest were mainly number and size of particles, and a number of observed/avoided incompatibilities.
RESULTS: All in all, 382 articles were screened, 17 meeting all the acceptance criteria. The strategies outlined and assessed were filtration, the use of multi-lumen devices, the purging of infusion lines, incompatibility tables and databases, and the use of standard operating procedures.
CONCLUSION: Although many strategies have been developed in recent years to address drug incompatibility risks, clinical data is still lacking. All studies with in vitro design were excluded although some current innovative strategies, like niosomes, should be considered and studied by means of clinical data in the future.
© 2021. The Author(s), under exclusive licence to Springer-Verlag GmbH, DE part of Springer Nature.

Entities:  

Keywords:  Drug incompatibility; Filtration; Infusions; Intensive care units; Intravenous; Particulate matter

Mesh:

Year:  2021        PMID: 33768303     DOI: 10.1007/s00228-021-03112-1

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  66 in total

1.  Particulate matter contamination of intravenous antibiotics aggravates loss of functional capillary density in postischemic striated muscle.

Authors:  Hans-Anton Lehr; Joachim Brunner; Ramzan Rangoonwala; C James Kirkpatrick
Journal:  Am J Respir Crit Care Med       Date:  2002-02-15       Impact factor: 21.405

2.  Total parenteral nutrition associated crystalline precipitates resulting in pulmonary artery occlusions and alveolar granulomas.

Authors:  Terry McNearney; Christopher Bajaj; Michael Boyars; John Cottingham; Abida Haque
Journal:  Dig Dis Sci       Date:  2003-07       Impact factor: 3.199

3.  Pulmonary deposition of calcium phosphate crystals as a complication of home total parenteral nutrition.

Authors:  J B Knowles; G Cusson; M Smith; M D Sitrin
Journal:  JPEN J Parenter Enteral Nutr       Date:  1989 Mar-Apr       Impact factor: 4.016

4.  Microparticulate-induced phlebitis. Its prevention by in-line filtration.

Authors:  K H Falchuk; L Peterson; B J McNeil
Journal:  N Engl J Med       Date:  1985-01-10       Impact factor: 91.245

5.  Microvascular pulmonary emboli secondary to precipitated crystals in a patient receiving total parenteral nutrition: a case report and description of the high-resolution CT findings.

Authors:  J S Reedy; J E Kuhlman; M Voytovich
Journal:  Chest       Date:  1999-03       Impact factor: 9.410

6.  Intravenous ceftriaxone and calcium in the neonate: assessing the risk for cardiopulmonary adverse events.

Authors:  John S Bradley; Ronald T Wassel; Lucia Lee; Sumathi Nambiar
Journal:  Pediatrics       Date:  2009-03-16       Impact factor: 7.124

7.  Particulate matter in injectable drug products.

Authors:  Stephen E Langille
Journal:  PDA J Pharm Sci Technol       Date:  2013 May-Jun

8.  In-line filtration reduces severe complications and length of stay on pediatric intensive care unit: a prospective, randomized, controlled trial.

Authors:  Thomas Jack; Martin Boehne; Bernadette E Brent; Ludwig Hoy; Harald Köditz; Armin Wessel; Michael Sasse
Journal:  Intensive Care Med       Date:  2012-04-12       Impact factor: 17.440

9.  In-line Filtration Decreases Systemic Inflammatory Response Syndrome, Renal and Hematologic Dysfunction in Pediatric Cardiac Intensive Care Patients.

Authors:  Michael Sasse; Friederike Dziuba; Thomas Jack; Harald Köditz; Torsten Kaussen; Harald Bertram; Philipp Beerbaum; Martin Boehne
Journal:  Pediatr Cardiol       Date:  2015-04-07       Impact factor: 1.655

10.  In-line filtration minimizes organ dysfunction: new aspects from a prospective, randomized, controlled trial.

Authors:  Martin Boehne; Thomas Jack; Harald Köditz; Kathrin Seidemann; Florian Schmidt; Michaela Abura; Harald Bertram; Michael Sasse
Journal:  BMC Pediatr       Date:  2013-02-06       Impact factor: 2.125

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.